Carocell Bio receives ethical approval for human pre-clinical testing of lead proprietary peptide in collaboration with Oxford clinical researcher
Testing anti-inflammation approach to treat burns and scarring is key step in therapeutic development and potential progression to clinical testing GREATER MANCHESTER, UK – 17 May 2022 – Today, Carocell Bio has announced that it has received approval from the Health Research Authority (HRA) to test its lead candidate proprietary peptide JEL3108 in human burns […]